Selected article for: "mesenchymal stem cell and msc mesenchymal stem cell"
Author: Tang, Lingling; Jiang, Yingan; Zhu, Mengfei; Chen, Lijun; Zhou, Xiaoyang; Zhou, Chenliang; Ye, Peng; Chen, Xiaobei; Wang, Baohong; Xu, Zhenyu; Zhang, Qiang; Xu, Xiaowei; Gao, Hainv; Wu, Xiaojun; Li, Dong; Jiang, Wanli; Qu, Jingjing; Xiang, Charlie; Li, Lanjuan
Title: Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19
  • Cord-id: g04kwtjn
  • Document date: 2020_8_6
    • ID: g04kwtjn
    Snippet: The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with severe cases of COVID-19. Herein, we describe two confirmed cases of COVID-19 in Wuhan to explore the role of MSC in the treatment of COVID-19. MSC transplantation increases the immune indicators (includ
    Document: The Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was identified in December 2019. The symptoms include fever, cough, dyspnea, early symptom of sputum, and acute respiratory distress syndrome (ARDS). Mesenchymal stem cell (MSC) therapy is the immediate treatment used for patients with severe cases of COVID-19. Herein, we describe two confirmed cases of COVID-19 in Wuhan to explore the role of MSC in the treatment of COVID-19. MSC transplantation increases the immune indicators (including CD4 and lymphocytes) and decreases the inflammation indicators (interleukin-6 and C-reactive protein). High-flow nasal cannula can be used as an initial support strategy for patients with ARDS. With MSC transplantation, the fraction of inspired O(2) (FiO(2)) of the two patients gradually decreased while the oxygen saturation (SaO(2)) and partial pressure of oxygen (PO(2)) improved. Additionally, the patients’ chest computed tomography showed that bilateral lung exudate lesions were adsorbed after MSC infusion. Results indicated that MSC transplantation provides clinical data on the treatment of COVID-19 and may serve as an alternative method for treating COVID-19, particularly in patients with ARDS.

    Search related documents:
    Co phrase search for related documents
    • acid detection and liver function: 1
    • acid detection and long term follow: 1, 2
    • acid detection and long term safety: 1
    • acid detection and low density: 1
    • acid detection and low immunogenicity: 1
    • acid detection and lung function: 1, 2
    • acid detection and lung injury: 1, 2
    • acid detection and lung tissue: 1, 2, 3
    • acid detection and lymphocyte increase: 1, 2
    • acute ards respiratory distress syndrome and administration prior: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and admission acute respiratory distress symptom: 1
    • acute ards respiratory distress syndrome and admission acute respiratory distress symptom patient: 1
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver support: 1, 2, 3
    • acute ards respiratory distress syndrome and long term follow: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and long term follow lack: 1
    • acute ards respiratory distress syndrome and long term safety: 1
    • acute ards respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low immunogenicity: 1, 2, 3